Wound Care News and Research

RSS
Smartphone solutions for clinical trials

Smartphone solutions for clinical trials

Physicians face medical challenges in treating spine trauma in morbidly obese patients

Physicians face medical challenges in treating spine trauma in morbidly obese patients

TriStar Wellness Solutions completes acquisition of HemCon Medical Technologies

TriStar Wellness Solutions completes acquisition of HemCon Medical Technologies

Derma Sciences initiates patient screening in DSC127 pivotal program for treatment of diabetic foot ulcers

Derma Sciences initiates patient screening in DSC127 pivotal program for treatment of diabetic foot ulcers

Scioderm completes Series A financing commitment totaling $16 million

Scioderm completes Series A financing commitment totaling $16 million

Pergamum reaches LPLV in Phase I/II trial of LL-37 for treatment of hard-to-heal venous leg ulcers

Pergamum reaches LPLV in Phase I/II trial of LL-37 for treatment of hard-to-heal venous leg ulcers

Woodside Capital to assist in growth of Spectros' flagship product

Woodside Capital to assist in growth of Spectros' flagship product

AAWC translates patient education brochure on pressure ulcers into Spanish

AAWC translates patient education brochure on pressure ulcers into Spanish

New research to focus on sensors for advanced wound care

New research to focus on sensors for advanced wound care

Sanford Health announces new limb preservation program

Sanford Health announces new limb preservation program

EO2 Concepts develops innovative dressing for difficult-to-heal wounds

EO2 Concepts develops innovative dressing for difficult-to-heal wounds

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

Cardinal Health announces plans to acquire AssuraMed

Cardinal Health announces plans to acquire AssuraMed

FDA allows Scioderm’s SD-101 IND application for Epidermolysis Bullosa to proceed

FDA allows Scioderm’s SD-101 IND application for Epidermolysis Bullosa to proceed

Shire commences ABH001 Phase 3 study in Epidermolysis Bullosa

Shire commences ABH001 Phase 3 study in Epidermolysis Bullosa

Misonix revenue increases 19% to $8.0M for six months ended December 31, 2012

Misonix revenue increases 19% to $8.0M for six months ended December 31, 2012

Enterprise Ireland welcomes Irish Minister to its pavilion at Arab Health 2013

Enterprise Ireland welcomes Irish Minister to its pavilion at Arab Health 2013

Project shows simple steps reduce hospital infections

Project shows simple steps reduce hospital infections

Diabetic foot complication risk highlighted in men

Diabetic foot complication risk highlighted in men

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.